Bristol Myers Squibb Adopts Veeva Systems Inc. (VEEV)'s Veeva Vault CRM, Boosting Market Confidence

We recently compiled a list of the 12 Best Healthcare Stocks to Buy and Hold for 5 Years. Veeva Systems Inc. is one of them.

Veeva Systems Inc. (NYSE:VEEV), a leading provider of cloud-based software for the life sciences industry, continues to expand its influence through platforms such as Veeva Commercial Cloud, Data Cloud, and Development Cloud. Serving more than 1,500 global customers, the company operates as a Public Benefit Corporation, reflecting its commitment to balancing stakeholder interests.

A major endorsement came recently from Bristol Myers Squibb, which adopted Veeva Vault CRM, reinforcing VEEV’s strong position in the sector. Looking ahead, the company will host a Virtual Investor Day on October 16, 2025, expected to outline future strategies and product innovations.

Financially, Veeva Systems Inc. (NYSE:VEEV) remains on solid ground with revenue up 16.7% year-over-year and free cash flow of about $1.18 billion (TTM as of August 22), which it reinvests into growth rather than paying dividends. Analysts remain optimistic, with an average price target suggesting nearly 14% upside. The company’s forward P/E ratio also signals market confidence in continued double-digit revenue expansion.

Strategically, the corporation is capitalizing on the growing demand for digital transformation in healthcare. By integrating AI capabilities into its platforms, the company is positioning itself at the forefront of cloud-based, generative AI-enabled solutions for pharmaceutical and biotechnology clients.

While we acknowledge the potential of VEEV as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy NOW 

Disclosure: None.